A 77-year-old man is evaluated in follow-up for prostate cancer. He is asymptomatic and feels well. He was diagnosed with high-grade prostate cancer 3 years ago and was treated with external-beam radiation therapy. Since that time, he has undergone regular surveillance.

His most recent serum prostate-specific antigen level rose from undetectable to 120 ng/mL (120 µg/L). A subsequent abdominopelvic CT scan showed an increase in regional lymphadenopathy and multiple sclerotic bony lesions in the visualized pelvis and spine.

The patient has been actively engaged in his medical care and has expressed a desire to be made aware of all information about his health status. The patient has scheduled this visit to discuss the results of his prostate cancer surveillance testing, and the physician indicates to the patient that, unfortunately, he has bad news to convey.

Which of the following is the most appropriate approach to conveying this news to the patient?